Summit Therapeutics (SMMT) Receivables - Other (2018 - 2025)
Summit Therapeutics (SMMT) has disclosed Receivables - Other for 4 consecutive years, with $12000.0 as the latest value for Q1 2025.
- For the quarter ending Q1 2025, Receivables - Other changed N/A year-over-year to $12000.0, compared with a TTM value of $12000.0 through Mar 2025, changed N/A, and an annual FY2021 reading of $574000.0, changed N/A over the prior year.
- Receivables - Other was $12000.0 for Q1 2025 at Summit Therapeutics, down from $90000.0 in the prior quarter.
- Across five years, Receivables - Other topped out at $1.1 million in Q2 2022 and bottomed at $12000.0 in Q1 2025.
- Average Receivables - Other over 4 years is $397833.3, with a median of $322500.0 recorded in 2022.